triamcinolone acetonide
triamcinolone acetonide: sourced relationships with 2 companies · 8 clinical trials tracked · 3 FDA decisions.
triamcinolone acetonide evidence translation
What we can confirm
3 FDA records · 8 tracked trials
What it means
What to watch
Prepared research question
What is verified about triamcinolone acetonide, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 1 study sponsors
Related indications
Study sponsors
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| PERRIGO Co plc (PRGO) Reported 2009-07-30 · Current development: unknownSource Uses temporarily relieves these symptoms of hay fever or oth… | Approved |
| DR REDDYS LABORATORIES LTD (RDY) Reported 2025-03-12 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (8)
Evaluation of UV-Trichoscopic Red Fluorescence Intensity in Relation to Trichoscopic Findings and Response to Intralesional Corticosteroid Treatment in Limited Plaque-Type Alopecia Areata
Primary endpoint: Association Between Baseline UV-Trichoscopic Red Fluorescence Intensity and Timing of First Visible Hair Regrowth
A Phase 3, Prospective, Multicenter, Randomized, Parallel-Arm, Double-Masked, Placebo-Controlled Study Evaluating the Safety and Efficacy of TRIESENCE® (Injectable Suspension) for the Treatment of Ocular Inflammation and Pain After Ophthalmic Surgery
Primary endpoint: Proportion of Subjects With No Anterior Chamber Cells (Grade 0) at Day 14
The Effect of Topical Triamcinolone Acetonide Application on Wound Healing in the Palatal Donor Site Following Free Gingival Graft Surgery
Primary endpoint: Oral Health-Related Quality of Life
Comparison of Ultrasound-Guided Triamcinolone Injection and Transcutaneous Electrical Nerve Stimulation for the Treatment of Long Head of the Biceps Brachii Tendinopathy
Primary endpoint: Visual Analog Scale (VAS) for Pain
Comparison of the Outcome of Treatment of Intralesional Triamcinolone Acetonide With Intralesional Verapamil Hydrochloride in Patients Presenting With Keloid at Tertiary Care Hospital, Bahawalpur.
Primary endpoint: Scar assessment
Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis: a Randomized Controlled Superiority Trial
Primary endpoint: Constant score
Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis (ADRN-12)
Primary endpoint: Mild (EASI ≤ 7) vs. moderate-to-severe (EASI > 7) AD severity between type 2-high vs. type 2-low endotype from non-lesional skin transcriptome in the dupilumab-naïve AD adults and children.
Symptom Clusters in Children With Exacerbation-prone Asthma
Primary endpoint: Change in Asthma Control Questionnaire (ACQ) Score
FDA Decisions3 records
Frequently asked questions
Which companies have sourced relationships with triamcinolone acetonide?
triamcinolone acetonide has dated SEC/FDA relationship records for PERRIGO Co plc, DR REDDYS LABORATORIES LTD.
How many clinical trials involve triamcinolone acetonide?
BioSniper tracks 8 clinical trials involving triamcinolone acetonide.
What is triamcinolone acetonide's latest FDA decision?
The most recent tracked FDA decision for triamcinolone acetonide is Approval for INDICATIONS AND USAGE Intramuscular Where oral therapy is not feasible, injectable corticosteroid therapy, including triamcinolone acetonide injectable suspension is indicated for intramuscular use as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reaction, dated April 11, 2025.